|
1
|
Shi X, Zhuo H, Du Y, Nyhan K, Ioannidis J
and Wallach JD: Environmental risk factors for non-Hodgkin's
lymphoma: Umbrella review and comparison of meta-analyses of
summary and individual participant data. BMJ Med.
1(e000184)2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chu Y, Liu Y, Fang X, Jiang Y, Ding M, Ge
X, Yuan D, Lu K, Li P, Li Y, et al: The epidemiological patterns of
non-Hodgkin lymphoma: Global estimates of disease burden, risk
factors, and temporal trends. Front Oncol.
13(1059914)2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mafra A, Laversanne M, Gospodarowicz M,
Klinger P, De Paula Silva N, Piñeros M, Piñeros M,
Steliarova-Foucher E, Bray F and Znaor A: Global patterns of
non-Hodgkin lymphoma in 2020. Int J Cancer. 151:1474–1481.
2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Garg M, Takyar J, Dhawan A, Saggu G,
Agrawal N, Hall A, Raut M and Ryland KE: Diffuse large B-cell
lymphoma (DLBCL): A structured literature review of the
epidemiology, treatment guidelines, and real-world treatment
patterns. Blood. 140 (Suppl 1):S12106–S12107. 2022.
|
|
5
|
Berhan A, Almaw A, Damtie S and Solomon Y:
Diffuse large B cell lymphoma (DLBCL): Epidemiology,
pathophysiology, risk stratification, advancement in diagnostic
approaches and prospects: Narrative review. Discov Oncol.
16(184)2025.PubMed/NCBI View Article : Google Scholar
|
|
6
|
He MY and Kridel R: Treatment resistance
in diffuse large B-cell lymphoma. Leukemia. 35:2151–2165.
2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Walker JS, Wenzl K, Novak JP, Stokes ME,
Hopper MA, Dropik AR, Siminski MS, Bock AM, Sarangi V, Ortiz M, et
al: Integrated genomics with refined cell-of-origin subtyping
distinguishes subtype-specific mechanisms of treatment resistance
and relapse in diffuse large B-cell lymphoma. Blood Cancer J.
15(120)2025.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Candelaria M and Dueñas-Gonzalez A:
Rituximab in combination with cyclophosphamide, doxorubicin,
vincristine, and prednisone (R-CHOP) in diffuse large B-cell
lymphoma. Ther Adv Hematol. 12(2040620721989579)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Susanibar-Adaniya S and Barta SK: 2021
Update on diffuse large B cell lymphoma: A review of current data
and potential applications on risk stratification and management.
Am J Hematol. 96:617–629. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Vietri M, Miranda MR, Amodio G, Ciaglia T,
Bertamino A, Campiglia P, Remondelli P, Vestuto V and Moltedo O:
The link between endoplasmic reticulum stress and lysosomal
dysfunction under oxidative stress in cancer cells. Biomolecules.
15(930)2025.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zuo H, Chen C and Sa Y: Therapeutic
potential of autophagy in immunity and inflammation: Current and
future perspectives. Pharmacol Rep. 75:499–510. 2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xu H, Yu X, Yang Z, Song Q, Cheng S, He Z
and Dai L: PAX5-activated lncRNA ARRDC1-AS1 accelerates the
autophagy and progression of DLBCL through sponging miR-2355-5p to
regulate ATG5. Life Sci. 286(119932)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kong YL, Pan BH, Liang JH, Zhu HY, Wang L,
Xia Y, Wu JZ, Fan L, Li JY and Xu W: Chidamide, a histone
deacetylase inhibitor, inhibits autophagy and exhibits therapeutic
implication in chronic lymphocytic leukemia. Aging (Albany NY).
12:16083–16098. 2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mouhssine S, Maher N, Matti BF, Alwan AF
and Gaidano G: Targeting BTK in B cell malignancies: From mode of
action to resistance mechanisms. Int J Mol Sci.
25(3234)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yan B, Guo J, Lai W, Chen Y, Wang Z, Peng
Y and Chang S: The multifaceted roles of ribosomal P. complex in
cancer. World J Surg Oncol. 23(388)2025.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chang C and Xu M: miR-4731-5p enhances
apoptosis and alleviates epithelial-mesenchymal transition through
targeting RPLP0 in non-small-cell lung cancer. J Oncol.
2022(3793318)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Pérez-Gómez JM, Porcel-Pastrana F, De La
Luz-Borrero M, Montero-Hidalgo AJ, Gómez-Gómez E, Herrera-Martínez
AD, Guzmán-Ruiz R, Malagón MM, Gahete MD and Luque RM: LRP10, PGK1
and RPLP0: Best reference genes in periprostatic adipose tissue
under obesity and prostate cancer conditions. Int J Mol Sci.
24(15140)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhou J, Li XY, Liu YJ, Feng J, Wu Y, Shen
HM and Lu GD: Full-coverage regulations of autophagy by ROS: From
induction to maturation. Autophagy. 18:1240–1255. 2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Omolekan TO, Chamcheu JC, Buerger C and
Huang S: PI3K/AKT/mTOR signaling network in human health and
diseases. Cells. 13(1500)2024.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Gomez Solsona B, Horn H, Schmitt A, Xu W,
Bucher P, Heinrich A, Kalmbach S, Kreienkamp N, Franke M, Wimmers
F, et al: Inhibition of glutaminase-1 in DLBCL potentiates
venetoclax-induced antitumor activity by promoting oxidative
stress. Blood Adv. 7:7433–7444. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Caserta S, Martino EA, Skafi M, Alvaro ME,
Bruzzese A, Amodio N, Lucia E, Olivito V, Labanca C, Mendicino F,
et al: Management of primary refractory diffuse large B-cell
lymphoma in patients unsuitable for CAR T-cell therapy. Eur J
Haematol. 116:771–784. 2026.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Brune V, Tiacci E, Pfeil I, Döring C,
Eckerle S, Van Noesel CJ, Klapper W, Falini B, von Heydebreck A,
Metzler D, et al: Origin and pathogenesis of nodular
lymphocyte-predominant Hodgkin lymphoma as revealed by global gene
expression analysis. J Exp Med. 205:2251–2268. 2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43(e47)2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Hata A and Hayama M: Selection of RT-PCR
assays and reliability of viral gene detection in water samples
containing RT-PCR inhibitors. Water Air Soil Pollut.
236(618)2025.
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xiang Y, Zheng Y, Liu S, Liu G, Li Z and
Dong W: Comparison of the sensitivity of western blotting between
PVDF and NC membranes. Sci Rep. 11(12022)2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bram Ednersson S, Stenson M, Stern M,
Enblad G, Fagman H, Nilsson-Ehle H, Hasselblom S and Andersson PO:
Expression of ribosomal and actin network proteins and
immunochemotherapy resistance in diffuse large B cell lymphoma
patients. Br J Haematol. 181:770–781. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Hagner PR, Mazan-Mamczarz K, Dai B, Balzer
EM, Corl S, Martin SS, Zhao XF and Gartenhaus RB: Ribosomal protein
S6 is highly expressed in non-Hodgkin lymphoma and associates with
mRNA containing a 5' terminal oligopyrimidine tract. Oncogene.
30:1531–1541. 2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liang ZX, Liu HS, Xiong L, Yang X, Wang
FW, Zeng ZW, He XW, Wu XR and Lan P: A novel NF-κB regulator
encoded by circPLCE1 inhibits colorectal carcinoma progression by
promoting RPS3 ubiquitin-dependent degradation. Mol Cancer.
20(103)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Park SY, Seo D, Jeon EH, Park JY, Jang BC,
Kim JI, Im SS, Lee JH, Kim S, Cho CH and Lee YH: RPL27 contributes
to colorectal cancer proliferation and stemness via PLK1 signaling.
Int J Oncol. 63(93)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Xu C, Lu Z, Hou G and Zhu M: Exploring the
function and prognostic value of RPLP0, RPLP1 and RPLP2 expression
in lung adenocarcinoma. J Mol Histol. 55:1079–11091.
2024.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Teller A, Jechorek D, Hartig R, Adolf D,
Reißig K, Roessner A and Franke S: Dysregulation of apoptotic
signaling pathways by interaction of RPLP0 and cathepsin X/Z in
gastric cancer. Pathol Res Pract. 211:62–70. 2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lin D, Fu R, Xi E and Bai Y (eds):
Computational prediction of biological signatures for candidate
driver genes associated with ovarian cancer. 2021 IEEE
International Conference on Bioinformatics and Biomedicine (BIBM).
IEEE, 2021.
|
|
34
|
Wang CH, Wang LK, Wu CC, Chen ML, Lee MC,
Lin YY and Tsai FM: The ribosomal protein RPLP0 mediates
PLAAT4-induced cell cycle arrest and cell apoptosis. Cell Biochem
Biophys. 77:253–260. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Murphy MP, Bayir H, Belousov V, Chang CJ,
Davies KJA, Davies MJ, Dick TP, Finkel T, Forman HJ,
Janssen-Heininger Y, et al: Guidelines for measuring reactive
oxygen species and oxidative damage in cells and in vivo. Nat
Metab. 4:651–662. 2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wu C, Chen S, Wu Z, Xue J, Zhang W, Wang
S, Zhao X and Wu S: Chidamide and orelabrutinib synergistically
induce cell cycle arrest and apoptosis in diffuse large B-cell
lymphoma by regulating the PI3K/AKT/mTOR pathway. J Cancer Res Clin
Oncol. 150(98)2024.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Muri J and Kopf M: The thioredoxin system:
Balancing redox responses in immune cells and tumors. Eur J
Immunol. 53(e2249948)2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kumari B: Cellular stress responses and
associated diseases: A focus on heat shock proteins. Cell Biochem
Biophys. 83:2793–2804. 2025.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Bonavita R, Vitale F, Verdicchio LV,
Williams SV, Caporaso MG, Fleming A and Renna M: Small HSPs at the
crossroad between protein aggregation, autophagy and unconventional
secretion: Clinical implications and potential therapeutic
opportunities in the context of neurodegenerative diseases. Front
Cell Dev Biol. 13(1538377)2025.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Feng Q, Hu K, Hu H, Lu Y, Zhang H, Wang G,
Zhang Q, Xu Z, Gao X, Jia X, et al: Berberine derivative DCZ0358
induce oxidative damage by ROS-mediated JNK signaling in DLBCL
cells. Int Immunopharmacol. 125(111139)2023.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Du X, Wei H, Zhang B, Pang LK, Zhao R,
Zhang XD and Yao W: Unveiling the prognostic implications of RPLP1
upregulation in osteosarcoma. Am J Cancer Res. 13:4822–4831.
2023.PubMed/NCBI
|
|
42
|
Meng Y, Yuan L, Meng G, Huang H, Huang X,
Xu X and Peng X: c-Myc-regulated RPLP0 via the ROS-mediated
JAK2/STAT3 positive feedback loop facilitates hepatocellular
carcinoma malignancy progression. Int J Oncol.
68(13)2026.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liu X, Hussain R, Mehmood K, Tang Z, Zhang
H and Li Y: Mitochondrial-endoplasmic reticulum
communication-mediated oxidative stress and autophagy. Biomed Res
Int. 2022(6459585)2022.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Prakash R, Fauzia E, Siddiqui AJ, Yadav
SK, Kumari N, Shams MT, Naeem A, Praharaj PP, Khan MA, Bhutia SK,
et al: Oxidative stress-induced autophagy compromises stem cell
viability. Stem Cells. 40:468–478. 2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhang YL, Ma MX, Xing LN, Zhang JN, Guo XN
and Qiao SK: Downregulation of autophagy is associated with poor
clinical outcome after immunochemotherapy in patients with diffuse
large B-cell lymphoma. Exp Hematol. 139(104638)2024.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chen Y, Wang F, Wu P, Gong S, Gao J, Tao
H, Shen Q, Wang S, Zhou Z and Jia Y: Artesunate induces apoptosis,
autophagy and ferroptosis in diffuse large B cell lymphoma cells by
impairing STAT3 signaling. Cell Signal. 88(110167)2021.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Iriondo MN, Etxaniz A, Varela YR,
Ballesteros U, Hervás JH, Montes LR, Goñi FM and Alonso A: LC3
subfamily in cardiolipin-mediated mitophagy: A comparison of the
LC3A, LC3B and LC3C homologs. Autophagy. 18:2985–3003.
2022.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Wei F, Qin N, Chen Y, Liu Z, Zhao X, Yu X,
Feng Z, Wang Y, Yang A and Cui H: ATG16L1 membrane recruitment in
autophagy. Crit Rev Biochem Mol Biol. 60:107–122. 2025.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Huang J, Chen L, Wu J, Ai D, Zhang JQ,
Chen TG and Wang L: Targeting the PI3K/AKT/mTOR signaling pathway
in the treatment of human diseases: Current status, trends, and
solutions. J Med Chem. 65:16033–16061. 2022.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Yi X, Zhang C, Liu B, Gao G, Tang Y, Lu Y,
Pan Z, Wang G and Feng W: Ribosomal protein L22-like1 promotes
prostate cancer progression by activating PI3K/Akt/mTOR signalling
pathway. J Cell Mol Med. 27:403–411. 2023.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Liu L, Wu Y, Liu K, Zhu M, Guang S, Wang
F, Liu X, Yao X, He J and Fu C: The absence of the ribosomal
protein Rpl2702 elicits the MAPK-mTOR signaling to modulate
mitochondrial morphology and functions. Redox Biol.
73(103174)2024.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Wang G, Liu H, An L, Hou S and Zhang Q:
CAPG facilitates diffuse large B-cell lymphoma cell progression
through PI3K/AKT signaling pathway. Hum Immunol. 83:832–842.
2022.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Li J, Chen X, Kang R, Zeh H, Klionsky DJ
and Tang D: Regulation and function of autophagy in pancreatic
cancer. Autophagy. 17:3275–3296. 2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Du J, Ye T, Li P, Yu Y, Fan F, Zhang R and
Shen N: Plumbagin induces apoptosis in diffuse large B-cell
lymphoma by modulating the ROS-PI3K-Akt-mTOR signaling pathway.
Crit Rev Eukaryot Gene Expr. 35:13–25. 2025.PubMed/NCBI View Article : Google Scholar
|
